Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Weekly News Recap #Phispers
1. (r)-2-(7-((4-cyclo-pentyl-3-(trifluoromethyl)benzyl)oxy)-1,2,3,4-tetrahydro-cyclopenta(b)indol-3-yl)acetic Acid)
1. 1206123-37-6
2. Apd334
3. Apd-334
4. Etrasimod [usan]
5. 6wh8495mmh
6. Apd-334(free Acid)
7. Chembl3358920
8. Etrasimod (usan)
9. 1206123-37-6 (free Base)
10. (r)-2-(7-((4-cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic Acid
11. (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta(b)indol-3-yl) Acetic Acid
12. 2-[(3r)-7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic Acid
13. Etrasimod(apd334)
14. Etrasimod [inn]
15. Etrasimod [who-dd]
16. Unii-6wh8495mmh
17. Apd334apd334
18. Gtpl9331
19. Schembl1919311
20. Bcp19558
21. Ex-a1633
22. Bdbm50041691
23. Akos032944972
24. Zinc117522788
25. Apd334-003
26. Compound 4 [pmid: 25516790]
27. Cs-6181
28. Db14766
29. Ac-35444
30. Hy-12789
31. D10930
32. F10118
33. Q27265630
34. ((3r)-7-((4-cyclopentyl-3-(trifluoromethyl)phenyl)methoxy)-1,2,3,4-tetrahydrocyclopenta(b)indol-3-yl)acetic Acid
35. (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic Acid
36. Cyclopent(b)indole-3-acetic Acid, 7-((4-cyclopentyl-3-(trifluoromethyl)phenyl)methoxy)-1,2,3,4-tetrahydro-, (3r)-
Molecular Weight | 457.5 g/mol |
---|---|
Molecular Formula | C26H26F3NO3 |
XLogP3 | 6.4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 6 |
Exact Mass | 457.18647818 g/mol |
Monoisotopic Mass | 457.18647818 g/mol |
Topological Polar Surface Area | 62.3 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 695 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
About the Company : Egis is a member of the Servier Group. Egis’ products are manufactured at 3 production sites in Hungary, which are certified by EMA,FDA, ANVISA, PMDA ,KFDA. Egis sells its produc...
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...
About the Company : Curia is a global contract research, development and manufacturing organization (CDMO), offering products and services across the drug development spectrum to help our partners tur...
About the Company : Hebi Xinhe Pharmaceutical Co., Ltd. is a subsidiary of Tianjin Zhennuo Pharmaceutical Group Co., Ltd., with a registered capital of CNY 100 million. Located in Jijiashan Industrial...
About the Company : Lewens Labs finds its roots in 4 years of engineering during which we saw a dream to carve out a niche for ourselves in Pharmaceutical Industry. As a part of the final year project...
About the Company : Livmore Life Sciences Pvt. Ltd., established in 2016, is a pharmaceutical company dedicated to the development, optimization, and manufacturing of high-quality Active Pharmaceutica...
Regulatory Info :
Registration Country : Norway
Brand Name : Wellsipity
Dosage Form : Tablet, film-coated
Dosage Strength : 2 mg
Packaging : Blisterpakning 28item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
https://www.pharmacompass.com/radio-compass-blog/fda-approvals-rise-49-in-2023-crispr-s-gene-editing-therapy-sees-light-of-day
Global Sales Information
Market Place
ABOUT THIS PAGE
35
PharmaCompass offers a list of Etrasimod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Etrasimod manufacturer or Etrasimod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Etrasimod manufacturer or Etrasimod supplier.
PharmaCompass also assists you with knowing the Etrasimod API Price utilized in the formulation of products. Etrasimod API Price is not always fixed or binding as the Etrasimod Price is obtained through a variety of data sources. The Etrasimod Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Etrasimod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Etrasimod, including repackagers and relabelers. The FDA regulates Etrasimod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Etrasimod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Etrasimod manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Etrasimod supplier is an individual or a company that provides Etrasimod active pharmaceutical ingredient (API) or Etrasimod finished formulations upon request. The Etrasimod suppliers may include Etrasimod API manufacturers, exporters, distributors and traders.
click here to find a list of Etrasimod suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Etrasimod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Etrasimod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Etrasimod GMP manufacturer or Etrasimod GMP API supplier for your needs.
A Etrasimod CoA (Certificate of Analysis) is a formal document that attests to Etrasimod's compliance with Etrasimod specifications and serves as a tool for batch-level quality control.
Etrasimod CoA mostly includes findings from lab analyses of a specific batch. For each Etrasimod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Etrasimod may be tested according to a variety of international standards, such as European Pharmacopoeia (Etrasimod EP), Etrasimod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Etrasimod USP).